Autor: Penman, Alan 
50 Studies Every Ophthalmologist Should Know
1st Edition 2020, 352 p.

About the book: 

50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.

Table of Contents:

1. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation

2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis

3. Topical Corticosteroids for Bacterial Keratitis

4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer

5. Prevalence of Age-Related Lens Opacities in a Population

6. Risk Factors for Cataract

7. High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss

8. Routine Preoperative Medical Testing Before Cataract Surgery.

9. Prophylaxis of Postoperative Endophthalmitis Following Cataract Surgery

10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma

11. Is argon laser trabeculoplasty equivalent to topical medication as an initial treatment for primary open-angle glaucoma?

12. Intraocular Pressure Reduction in the Treatment of Normal-Tension Glaucoma

13. The Relationship Between Control of Intraocular Pressure after Surgical Intervention for Glaucoma and Visual Field Deterioration

14. Reduction of intraocular pressure and glaucoma progression

15. Topical ocular hypotensive medication to delay or prevent the onset of primary open-angle glaucoma

16. Intraocular Pressure Control and Long-Term Visual Field Loss in Open-Angle Glaucoma

17. Latanoprost for Open-Angle Glaucoma

18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma

19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study

20. Risk Factors for Branch and Central Retinal Vein Occlusion

21. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion

22. Intraocular Injections of Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion

23. Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion

24. Steroids in the Treatment of Central Retinal Vein Occlusion

25. Cryotherapy for Retinopathy of Prematurity

26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of Prematurity

27. Early Treatment of Prethreshold Retinopathy of Prematurity

28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

29. Photocoagulation for Diabetic Macular Edema

30. Early Photocoagulation for Diabetic Retinopathy

31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients with Complications of Proliferative Diabetic Retinopathy

32. Intensive Diabetes Management to Reduce the Risk of Retinopathy Developing or Progressing

33. Progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus

34. Immediate Vitrectomy and Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis

35. Prevalence of Age-Related Maculopathy

36. Does high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of age-related macular degeneration and vision loss?

37. Argon laser photocoagulation for extrafoveal neovascular maculopathy

38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration with Verteporfin

39. Pegaptanib for Neovascular Age-Related Macular Degeneration

40. Ranibizumab for Neovascular Age-Related Macular Degeneration

41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

42. Effect of Pre-Enucleation Radiation on Mortality in Large Choroidal Melanomas

43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide

44. Botulinum A Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery

45. Botulinum A Toxin Injection as a Treatment for Blepharospasm

46. A Clinical Activity Score That Discriminates Between Inflammatory and Non-Inflammatory Graves' Ophthalmopathy

47. Corticosteroids in the Treatment of Acute Optic Neuritis

48. Atropine or Patching for Treatment of Moderate Amblyopia in Children

49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia During Infancy

50. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss